Huntsman Cancer Institute (HCI) has a robust and highly interactive Senior Leadership team comprised of eight individuals: HCI Executive Director: Mary Beckede, PhD Senior Director of Finance and Administration: Scott Lloyd, MBA, CPA Senior Director of Basic Science: Barbara Graves, PhD Senior Director of Early Translational Research: David Jones, PhD Senior Director of Clinical Research: Sunil Sharma, MD Senior Director of Community Oncology Research: Wallace Akerley, MD Senior Director of Prevention and Outreach: Randall Burt, MD Senior Director of Clinical Affairs: Sean Mulvihill, MD Huntsman Cancer Hospital (HCH) Executive Director: Ray Lynch, MBA, CPA The Senior Leadership is responsible for strategic planning, integration, financial management, and evaluation of all three areas of the HCI mission: research, clinical care, and education/outreach. In the research arena, members of the Senior Leadership oversee CCSG Programs, Shared Resources, and Support Services such as the Protocol Review and Monitoring System. They also provide leadership regarding data and safety monitoring as well as participation of minorities and children in clinical trials. HCI Senior Leadership forms the Director's Cabinet. The Cabinet meets weekly for one to two hours with an agenda and holds a two-to-three day off-site retreat in the winter each year, as well as a multi-day spring conference to review and finalize the next year's budget. In addition, each Senior Leader meets individually with Dr. Beckerle on a regulady scheduled weekly, bi-weekly, or monthly (minimum level) calendar, depending on particular needs. The Executive Director and Senior Directors of Finance and Administration, Basic Science, Eady Translational Research, Clinical Research, Community Oncology Research, and Prevention and Outreach are members of the Research Leadership Council, which leads the direction of the Cancer Center's research Programs and support services. Section 7.1 describes the key appointments, credentials, and responsibilities of the Executive Director and each Cabinet member, which are critical to achieve the strategic goals of HCI as an NCI-Designated Cancer Center. Though not directly involved in leading the CCSG efforts, the Senior Director of Clinical Affairs and HCH Executive Director support the goals of the CCSG by overseeing clinical operations and planning as well as facilitating integration of HCI's research and clinical care missions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-25
Application #
8661118
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
25
Fiscal Year
2014
Total Cost
$84,701
Indirect Cost
$19,957
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Khorashad, J S; Tantravahi, S K; Yan, D et al. (2016) Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy. Leukemia 30:2275-2279
Flores, Kristina G; Steffen, Laurie E; McLouth, Christopher J et al. (2016) Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. J Genet Couns :
Neklason, Deborah W; VanDerslice, James; Curtin, Karen et al. (2016) Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer 23:93-100
(2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53:800-811
Norton, Maria C; Fauth, Elizabeth; Clark, Christine J et al. (2016) Family member deaths across adulthood predict Alzheimer's disease risk: The Cache County Study. Int J Geriatr Psychiatry 31:256-63
Piccolo, Stephen R; Hoffman, Laura M; Conner, Thomas et al. (2016) Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility. Mol Syst Biol 12:860
Zhu, Judy; Fleming, Aaron M; Orendt, Anita M et al. (2016) pH-Dependent Equilibrium between 5-Guanidinohydantoin and Iminoallantoin Affects Nucleotide Insertion Opposite the DNA Lesion. J Org Chem 81:351-9
Riedl, Jan; Fleming, Aaron M; Burrows, Cynthia J (2016) Sequencing of DNA Lesions Facilitated by Site-Specific Excision via Base Excision Repair DNA Glycosylases Yielding Ligatable Gaps. J Am Chem Soc 138:491-4
Serpico, Victoria; Liepert, Amy E; Boucher, Kenneth et al. (2016) The Effect of Previsit Education in Breast Cancer Patients: A Study of a Shared-decision-making Tool. Am Surg 82:259-65
Camp, Nicola J; Lin, Wei-Yu; Bigelow, Alex et al. (2016) Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Res 76:1916-25

Showing the most recent 10 out of 1049 publications